kynurenic acid has been researched along with quinpirole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hitzemann, RJ; Rubinstein, JE | 1 |
| Brotchie, JM; Fox, SH; Moser, B | 1 |
2 other study(ies) available for kynurenic acid and quinpirole
| Article | Year |
|---|---|
Further evidence against the coupling of dopamine receptors to phosphoinositide hydrolysis in rat striatum.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Carbachol; Corpus Striatum; Culture Techniques; Dopamine Agents; Drug Interactions; Ergolines; Glutathione; Hydrolysis; Inositol Phosphates; Kynurenic Acid; Male; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Scopolamine | 1990 |
Behavioral effects of 5-HT2C receptor antagonism in the substantia nigra zona reticulata of the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dopamine Agonists; Excitatory Amino Acid Antagonists; Indoles; Kynurenic Acid; Locomotion; Male; Microinjections; Oxidopamine; Parkinson Disease, Secondary; Pyridines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin Antagonists; Substantia Nigra; Sympatholytics; Urea | 1998 |